Accel-Rx Health Sciences Accelerator
14
1M
14
1.40
2
2
- Areas of investment
Summary
Accel-Rx Health Sciences Accelerator appeared to be the VC, which was created in 2014. The leading representative office of defined VC is situated in the Vancouver. The company was established in North America in Canada.
The high activity for fund was in 2016. The fund is generally included in less than 2 deals every year. Deals in the range of 1 - 5 millions dollars are the general things for fund. Considering the real fund results, this VC is 6 percentage points less often commits exit comparing to other organizations.
Besides, a startup needs to be aged 2-3 years to get the investment from the fund. Among the most popular portfolio startups of the fund, we may highlight Flosonics, Inversago Pharma. The fund has no specific favorite in a number of founders of portfolio startups. We can highlight the next thriving fund investment areas, such as Pharmaceutical, Clinical Trials. For fund there is a match between the country of its foundation and the country of its the most frequent investments - Canada.
The typical case for the fund is to invest in rounds with 4-5 participants. Despite the Accel-Rx Health Sciences Accelerator, startups are often financed by StartUp Health. The meaningful sponsors for the fund in investment in the same round are BDC Venture Capital, Lumira Ventures, Genesys Capital. In the next rounds fund is usually obtained by Lumira Ventures, Remiges Ventures, Fonds de solidaritu00e9 FTQ.
Investments analytics
Analytics
- Total investments
- 14
- Lead investments
- 2
- Exits
- 2
- Rounds per year
- 1.40
- Investments by industry
- Biotechnology (10)
- Health Care (8)
- Pharmaceutical (6)
- Medical (5)
- Medical Device (2) Show 8 more
- Investments by region
-
- Canada (14)
- Peak activity year
- 2016
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 9
- Group Appearance index
- 0.64
- Avg. company exit year
- 7
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| ImStar Therapeutics | 08 Jun 2016 | Biotechnology, Neuroscience, Therapeutics | Seed | 1M | British Columbia, Vancouver, Canada |
| Flosonics | 29 Jan 2018 | Health Care, Medical Device, Medical | Seed | 5M | Ontario, Greater Sudbury, Canada |
| minisocial | 20 Jul 2020 | Social Media, Content Creators, Content Marketing | Seed | United States, New York, New York |
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.